Helland, Ane M.
Mydske, Sigurd
Assmus, Jörg
Brattebø, Guttorm
Wiggen, Øystein
Kvidaland, Haakon K.
Thomassen, Øyvind
Funding for this research was provided by:
The Norwegian Air Ambulance Foundation
University of Bergen
Article History
Received: 13 September 2024
Accepted: 22 January 2025
First Online: 31 January 2025
Declarations
:
: The protocol was approved by the Norwegian Ethics Committee for Clinical Trials on Medicinal Products and Medicinal Devices and the Regional Committee for Medicinal and Health Research Ethics Southeast Norway and registered in the EudraCT database (ID 2023–506020-81–00). Oral and written informed consent was obtained from all participants prior to participation.
: Not applicable.
: AMH, SM, JA and OT are employed by NAAF. NAAF had no role in the design of the study, do not have access to the data and were not involved in the process of analyzing, interpreting, or publishing the results.